Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice

Author： Morovat Alireza   Weerasinghe Gayani   Nesbitt Victoria   Hofer Monika   Agnew Thomas   Quaghebeur Geralrine   Sergeant Kate   Fratter Carl   Guha Nishan   Mirzazadeh Mehdi   Poulton Joanna  

Publisher： MDPI

E-ISSN： 2077-0383|6|8|80-80

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.6, Iss.8, 2017-08, pp. : 80-80

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutathione as a Redox Biomarker in Mitochondrial Disease—Implications for Therapy

By Enns Gregory M.   Cowan Tina M.  

Journal of Clinical Medicine, Vol. 6, Iss. 5, 2017-05 ,pp. : 50-50

MDPI

Access to resources Recommend Favorite

Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations

By Hamilton-Craig Ian   Kostner Karam Maximilien   Woodhouse Stan   Colquhoun David  

International Journal of Evidence-based Healthcare, Vol. 10, Iss. 3, 2012-09 ,pp. : 181-190

Blackwell Publishing

Access to resources Recommend Favorite

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

By Schwartzberg L.   Shiffman R.   Tomita D.   Stolshek B.   Rossi G.   Adamson R.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2781-2796

Elsevier

Access to resources Recommend Favorite

The Use of Progesterone in Clinical Practice: Evaluation of its Efficacy in Diverse Indications Using Different Routes of Administration

By  

Current Drug Therapy, Vol. 1, Iss. 2, 2006-05 ,pp. : 211-219

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarker

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 14-14

Nova Science Publishers, Inc.

Access to resources Recommend Favorite